drugset / Trial / NCT00746096

Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea

NCT00746096

Phase 3 Completed 115 enrolled Nobelpharma
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether combination oral contraceptive pill of norethindrone and ethinyl estradiol is effective in the treatment of primary dysmenorrhea.

Timeline

Start
2008-09
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Norethindrone Unknown 1 mg Oral
Subject ethinyl estradiol Small molecule 0.035 mg Oral

Indications